These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 35978219)

  • 21. Beta-blocker Therapy at Discharge in Patients with Acute Heart Failure and Atrial Fibrillation.
    Ahn MS; Yoo BS; Son JW; Yu MH; Kang DR; Lee HY; Jeon ES; Kim JJ; Chae SC; Baek SH; Kang SM; Choi DJ; Kim KH; Cho MC; Kim SY
    J Korean Med Sci; 2020 Aug; 35(33):e278. PubMed ID: 32830467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
    Grytli HH; Fagerland MW; Fosså SD; Taskén KA
    Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2014 Sep; (9):CD004476. PubMed ID: 25233038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction.
    Li S; Li X
    High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):405-411. PubMed ID: 31625118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease.
    Molnar AO; Petrcich W; Weir MA; Garg AX; Walsh M; Sood MM
    Nephrol Dial Transplant; 2020 May; 35(5):782-789. PubMed ID: 31495887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biased Exposure-Health Effect Estimates from Selection in Cohort Studies: Are Environmental Studies at Particular Risk?
    Weisskopf MG; Sparrow D; Hu H; Power MC
    Environ Health Perspect; 2015 Nov; 123(11):1113-22. PubMed ID: 25956004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimation of treatment effect adjusting for dependent censoring using the IPCW method: an application to a large primary prevention study for coronary events (MEGA study).
    Yoshida M; Matsuyama Y; Ohashi Y;
    Clin Trials; 2007; 4(4):318-28. PubMed ID: 17848493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database.
    Lafuma A; Berdeaux G
    Curr Med Res Opin; 2008 May; 24(5):1519-27. PubMed ID: 18413015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of β-blockers in heart failure with left ventricular systolic dysfunction and chronic kidney disease.
    Chang TI; Yang J; Freeman JV; Hlatky MA; Go AS
    J Card Fail; 2013 Mar; 19(3):176-82. PubMed ID: 23482078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perioperative beta-blockers for preventing surgery-related mortality and morbidity.
    Blessberger H; Kammler J; Domanovits H; Schlager O; Wildner B; Azar D; Schillinger M; Wiesbauer F; Steinwender C
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD004476. PubMed ID: 29533470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-Blockers for Exams Identify Students at High Risk of Psychiatric Morbidity.
    Butt JH; Dalsgaard S; Torp-Pedersen C; Køber L; Gislason GH; Kruuse C; Fosbøl EL
    J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):266-273. PubMed ID: 27782771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of All-Cause Mortality in Diabetic Patients Taking β-Blockers.
    Tsujimoto T; Kajio H; Shapiro MF; Sugiyama T
    Mayo Clin Proc; 2018 Apr; 93(4):409-418. PubMed ID: 29545006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Events After Discontinuation of β-Blockers in Patients Without Heart Failure Optimally Treated After Acute Myocardial Infarction: A Cohort Study on the French Healthcare Databases.
    Neumann A; Maura G; Weill A; Alla F; Danchin N
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004356. PubMed ID: 29653999
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Could treatments with beta-blockers be associated with a reduction in cancer risk?].
    Algazi M; Plu-Bureau G; Flahault A; Dondon MG; Lê MG
    Rev Epidemiol Sante Publique; 2004 Feb; 52(1):53-65. PubMed ID: 15107693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of follow-up and assessment of selection bias from dropouts using inverse probability weighting in a cohort of university graduates.
    Alonso A; Seguí-Gómez M; de Irala J; Sánchez-Villegas A; Beunza JJ; Martínez-Gonzalez MA
    Eur J Epidemiol; 2006; 21(5):351-8. PubMed ID: 16736275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of dynamic treatment regimes via inverse probability weighting.
    Hernán MA; Lanoy E; Costagliola D; Robins JM
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):237-42. PubMed ID: 16611197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection Bias Due to Loss to Follow Up in Cohort Studies.
    Howe CJ; Cole SR; Lau B; Napravnik S; Eron JJ
    Epidemiology; 2016 Jan; 27(1):91-7. PubMed ID: 26484424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impacts of β-blockers in acute coronary syndrome patients without heart failure treated by percutaneous coronary intervention.
    Chen RZ; Liu C; Zhou P; Li JN; Zhou JY; Wang Y; Zhao XX; Chen Y; Song L; Zhao HJ; Yan HB
    Pharmacol Res; 2021 Jul; 169():105614. PubMed ID: 33872810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
    Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
    BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effectiveness of beta-blockers after myocardial infarction in patients with type 2 diabetes.
    McDonald CG; Majumdar SR; Mahon JL; Johnson JA
    Diabetes Care; 2005 Sep; 28(9):2113-7. PubMed ID: 16123475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.